Flugen, Inc.

Madison, WI 53711

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.79MM
First Award Date 08/27/12
Most Recent Award Date 07/01/17

Key Personnel

Last Name Name Awards Contact
Bilsel Pamuk Bilsel 5
Kawaoka Yoshihiro Kawaoka 1
SARAWAR SALLY SARAWAR 2
IWASAKI AKIKO IWASAKI 2

5 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 07/01/17 - 06/30/18

Respiratory infections with influenza viruses cause severe morbidity and mortality in humans and animals worldwide. Importantly, in humans, the majority of morbidity and mortality following flu infection is seen in older individuals (> 65 years old). Yet, clear understanding of how aging impacts on innate immune responses, and how to improve vac...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 08/01/15 - 07/31/16

DESCRIPTION (provided by applicant): Respiratory infections with influenza viruses cause severe morbidity and mortality in humans and animals worldwide. Importantly, in humans, the majority of morbidity and mortality following flu infection is seen in older individuals (>65 year old). Yet, clear understanding of how aging impacts on innate immu...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): Seasonal influenza (flu) virus, an NIAID category C priority pathogen, causes widespread infection, resulting in at least 3-5 million cases of severe illness and 250,000-500,000 deaths worldwide. Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or dea...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 06/15/14 - 05/31/15

DESCRIPTION (provided by applicant): Seasonal influenza (flu) virus, an NIAID category C priority pathogen, causes widespread infection, resulting in at least 3-5 million cases of severe illness and 250,000-500,000 deaths worldwide. Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or dea...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-113
Budget: 08/27/12 - 07/31/13

DESCRIPTION (provided by applicant): A high-growth PR8 virus for pandemic vaccine production in ST6-Vero cells. In 2009, the traditional means of vaccine manufacturing for the H1N1 influenza pandemic failed to yield sufficient doses during the peak of the crisis. A vaccine production method that can universally accommodate variant strains of vi...